Cargando…
异基因造血干细胞移植治疗骨髓增生异常综合征的预后因素分析
OBJECTIVE: To evaluate the outcomes and prognostic factors of myelodysplasia syndrome (MDS) patients who received allogeneic hematopoietic stem cell transplantation (allo-HSCT). METHODS: 165 cases of MDS who underwent allo-HSCT from Jan. 2010 to Mar. 2018 were analyzed retrospectively, focusing on t...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342395/ https://www.ncbi.nlm.nih.gov/pubmed/31340621 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.06.007 |
Ejemplares similares
-
异基因造血干细胞移植治疗骨髓增生异常综合征研究进展
Publicado: (2016) -
我如何用异基因造血干细胞移植治疗骨髓增生异常综合征
Publicado: (2021) -
异基因造血干细胞移植治疗Shwachman Diamond综合征伴骨髓增生异常综合征1例
Publicado: (2023) -
异基因造血干细胞移植治疗儿童骨髓增生异常综合征/骨髓增殖性肿瘤10例疗效分析
Publicado: (2018) -
异基因造血干细胞移植治疗NPM1基因突变阳性骨髓增生异常综合征14例临床疗效
Publicado: (2023)